Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com
Dallas, TX (PRWEB) March 04, 2015 -- The report “Alopecia – Pipeline Review, H1 2015″ provides comprehensive information on the therapeutic development for Alopecia. Alopecia is the loss of hair. Alopecia areata and androgenetic alopecia are the two main types of alopecia. Causes for alopecia include aging, genetics, illness, chemotherapy, malnutrition and autoimmune disorder. Symptoms of alopecia may include male pattern hair loss, female diffuse hair loss, hairs easily removed and broken hair. Alopecia can be classified as focal or diffuse and by the presence or absence of scarring. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.rnrmarketresearch.com/alopecia-pipeline-review-h1-2015-market-report.html .
The report also reviews key players involved in the therapeutic development for alopecia and special features on late-stage and discontinued projects. Companies discussed in this Alopecia – Pipeline Review, H1 2015 report include AndroScience Corporation, Bristol-Myers Squibb Company, C3 Jian, Inc, Follicum AB, Kuhnil Pharmaceutical Co., Ltd., Lee's Pharmaceutical Holdings Limited, Panacea Biotec Limited, ProCertus BioPharm Inc., Taisho Pharmaceutical Co., Ltd., Tigo GmbH, Vida Therapeutics Inc.
Drugs profile discussed in this report include abatacept, ASCJ-9, calcitriol, DHL-HisZnNa, interferon beta-1b, KI-1104, KI-1105, Peptide for Alopecia, Peptide for Alopecia and Chemotherapy Effects, ProDermaCel, Recombinant Peptides for Alopecia, Recombinant Proteins to Antagonize IFN-Gamma Receptor for Alopecia Areata and Graft Arteriosclerosis, Small Molecule to Inhibit ALK5 for Alopecia and Fibrosis, Small Molecules to Activate P2Y5 Receptor for Alopecia, PCOS and Alopecia, V-2248, ZK-003.
Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=308842 . (This is a premium report priced at US$2000 for a single user License.)
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of content
List of Tables
Number of Products under Development for Alopecia, H1 2015
Number of Products under Development for Alopecia - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Investigation by Universities/Institutes, H1 2015
Alopecia - Pipeline by AndroScience Corporation, H1 2015
Alopecia - Pipeline by Bristol-Myers Squibb Company, H1 2015
Alopecia - Pipeline by C3 Jian, Inc, H1 2015
Alopecia - Pipeline by Follicum AB, H1 2015
Alopecia - Pipeline by Kuhnil Pharmaceutical Co., Ltd., H1 2015
Alopecia - Pipeline by Lee's Pharmaceutical Holdings Limited, H1 2015
Alopecia - Pipeline by Panacea Biotec Limited, H1 2015
Alopecia - Pipeline by ProCertus BioPharm Inc., H1 2015
Alopecia - Pipeline by Taisho Pharmaceutical Co., Ltd., H1 2015
Alopecia - Pipeline by Tigo GmbH, H1 2015
Alopecia - Pipeline by Vida Therapeutics Inc., H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Alopecia Therapeutics - Recent Pipeline Updates, H1 2015
Alopecia - Dormant Projects, H1 2015
Alopecia - Dormant Projects (Contd..1), H1 2015
Alopecia - Discontinued Products, H1 2015
List of Figures
Number of Products under Development for Alopecia, H1 2015
Number of Products under Development for Alopecia - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015
Explore more reports on Autoimmune Drugs at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment/autoimmune-drugs .
About Us:
RnRMarketResearch.com is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers.
Ritesh Tiwari, RnR Market Research, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]
Share this article